Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders

The aim of this study is to compare the pain intensity reduction between the mean radiation doses per session of gallium-aluminum-arsenide (GaAIAs) laser with superluminous diodes (SLD) in four of the most common pain-related chronic temporomandibular disorders (TMD) - local myalgia, myofascial pain...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sveshtarov Vasil, Nencheva-Sveshtarova S., Grozdanova R., Prodanova K.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2018
Materias:
R
Acceso en línea:https://doaj.org/article/f683496aff67435fb1fc3656034faf4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f683496aff67435fb1fc3656034faf4f
record_format dspace
spelling oai:doaj.org-article:f683496aff67435fb1fc3656034faf4f2021-12-02T19:11:32ZSuperluminous Devices Versus Low-Level Laser for Temporomandibular Disorders0324-175010.2478/amb-2018-0002https://doaj.org/article/f683496aff67435fb1fc3656034faf4f2018-03-01T00:00:00Zhttps://doi.org/10.2478/amb-2018-0002https://doaj.org/toc/0324-1750The aim of this study is to compare the pain intensity reduction between the mean radiation doses per session of gallium-aluminum-arsenide (GaAIAs) laser with superluminous diodes (SLD) in four of the most common pain-related chronic temporomandibular disorders (TMD) - local myalgia, myofascial pain, myofascial pain with a referral, and arthralgia. This study was implemented on 124 patients with pain-related temporomandibular disorders according to the DC/TMD criteria. We applied trigger point oriented near-infrared laser (785 nm, 100 s, 8 J/cm2) and SLD cluster sessions (the cluster is composed of 49 SLDs with a combination of visible red (633 nm) and infrared (880 nm) diodes, 200 mW, 300 s, 8 J/cm2) for the temporomandibular joints and the affected muscles. Patients were evaluated at the start of the treatment, and after the 6th session of combined phototherapy. The pain intensity scores were measured according to the Visual Analogue Scale (VAS). Our results show that the most statistically manifested pain reduction is found for the SLD dose, р = 0,000118, followed by the overall dose (laser plus SLD); р = 0,001031, and the laser dose; р = 0,030942 (ANOVA dispersion analyses). Consequently, it can be concluded that myalgia is better treated through lower doses of red light compared to infrared laser doses because SLDs combine the prooxidative effect of photons with 633 nm wavelength, a large area of exposure, sufficient tissue penetration, and some positive warming thermal impact of the SLD clusters.Sveshtarov VasilNencheva-Sveshtarova S.Grozdanova R.Prodanova K.Sciendoarticletemporomandibular pain-related disorderslow-level laser therapysuperluminous clustersMedicineRENActa Medica Bulgarica, Vol 45, Iss 1, Pp 11-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic temporomandibular pain-related disorders
low-level laser therapy
superluminous clusters
Medicine
R
spellingShingle temporomandibular pain-related disorders
low-level laser therapy
superluminous clusters
Medicine
R
Sveshtarov Vasil
Nencheva-Sveshtarova S.
Grozdanova R.
Prodanova K.
Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
description The aim of this study is to compare the pain intensity reduction between the mean radiation doses per session of gallium-aluminum-arsenide (GaAIAs) laser with superluminous diodes (SLD) in four of the most common pain-related chronic temporomandibular disorders (TMD) - local myalgia, myofascial pain, myofascial pain with a referral, and arthralgia. This study was implemented on 124 patients with pain-related temporomandibular disorders according to the DC/TMD criteria. We applied trigger point oriented near-infrared laser (785 nm, 100 s, 8 J/cm2) and SLD cluster sessions (the cluster is composed of 49 SLDs with a combination of visible red (633 nm) and infrared (880 nm) diodes, 200 mW, 300 s, 8 J/cm2) for the temporomandibular joints and the affected muscles. Patients were evaluated at the start of the treatment, and after the 6th session of combined phototherapy. The pain intensity scores were measured according to the Visual Analogue Scale (VAS). Our results show that the most statistically manifested pain reduction is found for the SLD dose, р = 0,000118, followed by the overall dose (laser plus SLD); р = 0,001031, and the laser dose; р = 0,030942 (ANOVA dispersion analyses). Consequently, it can be concluded that myalgia is better treated through lower doses of red light compared to infrared laser doses because SLDs combine the prooxidative effect of photons with 633 nm wavelength, a large area of exposure, sufficient tissue penetration, and some positive warming thermal impact of the SLD clusters.
format article
author Sveshtarov Vasil
Nencheva-Sveshtarova S.
Grozdanova R.
Prodanova K.
author_facet Sveshtarov Vasil
Nencheva-Sveshtarova S.
Grozdanova R.
Prodanova K.
author_sort Sveshtarov Vasil
title Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
title_short Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
title_full Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
title_fullStr Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
title_full_unstemmed Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
title_sort superluminous devices versus low-level laser for temporomandibular disorders
publisher Sciendo
publishDate 2018
url https://doaj.org/article/f683496aff67435fb1fc3656034faf4f
work_keys_str_mv AT sveshtarovvasil superluminousdevicesversuslowlevellaserfortemporomandibulardisorders
AT nenchevasveshtarovas superluminousdevicesversuslowlevellaserfortemporomandibulardisorders
AT grozdanovar superluminousdevicesversuslowlevellaserfortemporomandibulardisorders
AT prodanovak superluminousdevicesversuslowlevellaserfortemporomandibulardisorders
_version_ 1718377124454203392